Home

Arthur Fratamico

CIK 1598129 · Chief Business Officer · last filed 2023-03-29

Arthur Fratamico is a Chief Business Officer who has filed 13 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for PBLA, was dated Mar 29, 2023. Across all open-market trades the lifetime net is +$78.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $107 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$107

Companies

4

Total Filings

13

Lifetime Open-Market Net

$78.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PBLA Director 9,615 $0.01 $107 $0 3 2023-03-29
Galera Therapeutics, Inc. (GRTX) Delisted Chief Business Officer — $0.14 — $0 2 2021-01-28
Panbela Therapeutics, Inc. (SNBP) Delisted Director 2,424 — — $0 1 2020-09-01
Vitae Pharmaceuticals, Inc (VTAE) Delisted Chief Business Officer 0 — — $78.3K 5 2016-10-25

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-03-29 PBLA Grant (A) — $0 EDGAR
2021-05-27 PBLA Grant (A) +4,316 $0 EDGAR
2021-01-28 Galera Therapeutics, Inc. (GRTX) Delisted Grant (A) — $0 EDGAR
2020-12-03 PBLA Grant (A) +2,875 $0 EDGAR
2020-09-01 Panbela Therapeutics, Inc. (SNBP) Delisted Buy (P) +2,424 $0 EDGAR
2020-06-26 — Grant (A) — $0
2020-02-04 Galera Therapeutics, Inc. (GRTX) Delisted Grant (A) — $0 EDGAR
2019-12-23 — Grant (A) — $0
2016-10-25 Vitae Pharmaceuticals, Inc (VTAE) Delisted Mixed −13,233 -$277.9K EDGAR
2016-08-17 Vitae Pharmaceuticals, Inc (VTAE) Delisted Grant (A) +2,086 $12.7K EDGAR
Showing 1–10 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.